Influenza A virus N5 neuraminidase has an extended 150-cavity

J Virol. 2011 Aug;85(16):8431-5. doi: 10.1128/JVI.00638-11. Epub 2011 Jun 8.

Abstract

There are 9 serotypes of neuraminidase (NA) from influenza A virus (N1 to N9), which are classified into two groups based on primary sequences (groups 1 and 2). The structural hallmark of the two groups is the presence or absence of an extra 150-cavity (formed by the 150-loop) in the active site. Thus far, structures of NAs from 6 out of the 9 serotypes have been solved. Here, we solved the N5 structure, the last unknown structure group 1 serotype with a unique Asn147 residue in its 150-loop, demonstrating that it has an extended 150-cavity that closes upon inhibitor binding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Antiviral Agents / metabolism
  • Binding Sites
  • Crystallography, X-Ray
  • Influenza A Virus, H5N1 Subtype / chemistry
  • Influenza A Virus, H5N1 Subtype / genetics
  • Influenza A virus / chemistry*
  • Influenza A virus / genetics
  • Models, Molecular
  • Neuraminidase / chemistry*
  • Neuraminidase / metabolism
  • Protein Binding
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Sequence Alignment
  • Zanamivir / metabolism

Substances

  • Antiviral Agents
  • Neuraminidase
  • Zanamivir